Visvaldas Kairys

ResearcherID Ciência ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 9

Top Venues

Expert opinion on drug discovery

Proteins

Biomacromolecules

PloS one

Vilniaus Universitetas

University of Hawai'i (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vilniaus Universitetas Mar 11 2011

Lithuania

senior researcher :: Institute of Biotechnology

Education History

University of Hawai'i Sep 01 1992 - Dec 21 1997

United States

PHD :: Department of Chemistry

Publications

Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery 19 (6) (2024)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery 19 (6) (2024)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Asta Zubrienė, Vytautas Petrauskas, Daumantas Matulis, Egidijus Kazlauskas
Recent advances in computational and experimental protein-ligand affinity determination techniques. Expert opinion on drug discovery (2024)
Matthias Breindl, Dominika Spitzer, Ru Ta Gerasimaitė, Visvaldas Kairys, Thomas Schubert, Ramona Henfling, Uwe Schwartz, Gražvydas Lukinavičius, Laura Manelytė
Biochemical and cellular insights into the Baz2B protein, a non-catalytic subunit of the chromatin remodeling complex. Nucleic acids research (2023)
Benas Balandis, Tomas Šimkūnas, Vaida Paketurytė-Latvė, Vilma Michailovienė, Aurelija Mickevičiūtė, Elena Manakova, Saulius Gražulis, Sergey Belyakov, Visvaldas Kairys, Vytautas Mickevičius, Asta Zubrienė, Daumantas Matulis
Beta and Gamma Amino Acid-Substituted Benzenesulfonamides as Inhibitors of Human Carbonic Anhydrases. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Mara Gonçalves, Visvaldas Kairys, João Rodrigues, Helena Tomás
Polyester Dendrimers Based on Bis-MPA for Doxorubicin Delivery. Biomacromolecules (2021)
Justas Dapkunas, Visvaldas Kairys, Kliment Olechnovič, Česlovas Venclovas
Template-based modeling of diverse protein interactions in CAPRI rounds 38-45. Proteins 88 (8) (2019)
Visvaldas Kairys, Lina Baranauskienė, Migle Kazlauskiene, Daumantas Matulis, Egidijus Kazlauskas
Binding affinity in drug design: experimental and computational techniques. Expert opinion on drug discovery 14 (8) (2019)
Vytautas Raškevičius, Valeryia Mikalayeva, Ieva Antanavičiūtė, Ieva Ceslevičienė, Vytenis Arvydas Skeberdis, Visvaldas Kairys, Sergio Bordel
Genome scale metabolic models as tools for drug design and personalized medicine. PloS one 13 (1) (2018)
Vaida Morkūnaitė, Lina Baranauskienė, Asta Zubrienė, Visvaldas Kairys, Jekaterina Ivanova, Pēteris Trapencieris, Daumantas Matulis
Saccharin sulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII. BioMed research international 2014 (2014)

Visvaldas Kairys.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Visvaldas Kairys